International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: 670, P. 125180 - 125180
Published: Jan. 5, 2025
Language: Английский
International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: 670, P. 125180 - 125180
Published: Jan. 5, 2025
Language: Английский
AAPS PharmSciTech, Journal Year: 2025, Volume and Issue: 26(1)
Published: Jan. 17, 2025
Language: Английский
Citations
2ACS Nano, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 21, 2025
Nucleic acid therapeutics represent a highly promising treatment approach in modern medicine, treating diseases at the genetic level. However, these face numerous challenges practical applications, particularly regarding their stability, effectiveness, cellular uptake efficiency, and limitations delivering them specifically to target tissues. To overcome obstacles, researchers have developed various innovative delivery systems, including viral vectors, lipid nanoparticles, polymer inorganic protein carriers, exosomes, antibody oligonucleotide conjugates, DNA nanostructure-based systems. These systems enhance therapeutic efficacy of nucleic drugs by improving targeting specificity, half-life vivo. In this review, we systematically discuss different types drugs, analyze major barriers encountered delivery, summarize current research progress emerging We also highlight latest advancements application for diseases, infectious cancer, brain wound healing. This review aims provide comprehensive overview drug systems' status future directions integrating nanotechnology, biomaterials science, gene editing technologies, emphasizing transformative potential precision medicine.
Language: Английский
Citations
2International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125254 - 125254
Published: Jan. 1, 2025
Language: Английский
Citations
2Burns & Trauma, Journal Year: 2023, Volume and Issue: 11
Published: Jan. 1, 2023
The prevention and treatment of pathological scars remain challenging. Corticosteroids are the mainstay drugs in clinical scar as they effectively induce regression improve pruritus pain. Currently, intralesional injections corticosteroids widely used practice. These require professional medical manipulation; however, significant accompanying injection pain, repetition adverse effects, such skin atrophy, pigmentation telangiectasia, make this modality an unpleasant experience for patients. Transdermal administration is, therefore, a promising non-invasive easy-to-use method corticosteroid treatment. In review, we first summarize mechanisms action treatment; then, discuss current developments progress transdermal delivery systems corticosteroids, well their corresponding advantages disadvantages.
Language: Английский
Citations
29International Journal of Pharmaceutics, Journal Year: 2023, Volume and Issue: 637, P. 122880 - 122880
Published: March 21, 2023
Language: Английский
Citations
28Advanced Drug Delivery Reviews, Journal Year: 2023, Volume and Issue: 200, P. 115028 - 115028
Published: July 28, 2023
Lipid-based nanocarriers have been extensively investigated for their application in drug delivery. Particularly, liposomes are now clinically established treating various diseases such as fungal infections. In contrast, extracellular vesicles (EVs) - small cell-derived nanoparticles involved cellular communication just recently sparked interest carriers but development is still at the preclinical level. To drive this further, methods and technologies exploited context of liposome research should be applied domain EVs to facilitate accelerate clinical translation. One crucial steps EV-based therapeutics designing them proper dosage forms specific applications. This review offers a comprehensive overview state-of-the-art polysaccharide-based hydrogel platforms designed artificial natural with delivery skin. We discuss physicochemical biological properties try create sound basis optimization EV-embedded hydrogels versatile therapeutic avenues.
Language: Английский
Citations
23Acta Pharmaceutica Sinica B, Journal Year: 2024, Volume and Issue: 14(11), P. 4683 - 4716
Published: Sept. 2, 2024
About 40% of approved drugs and nearly 90% drug candidates are poorly water-soluble drugs. Low solubility reduces the drugability. Effectively improving bioavailability is a critical issue that needs to be urgently addressed in development application. This review briefly introduces conventional solubilization techniques such as solubilizers, hydrotropes, cosolvents, prodrugs, salt modification, micronization, cyclodextrin inclusion, solid dispersions, details crystallization strategies, ionic liquids, polymer-based, lipid-based, inorganic-based carriers bioavailability. Some most commonly used carrier materials for presented. Several using summarized. Furthermore, this summarizes mechanism each technique, reviews latest research advances challenges, evaluates potential clinical translation. could guide selection approach, dosage form, administration route Moreover, we discuss several promising attracting increasing attention worldwide.
Language: Английский
Citations
14ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(13), P. 15701 - 15717
Published: March 20, 2024
Although topical application of minoxidil is a widely used, FDA-approved therapy for androgenetic alopecia (AGA) treatment, it suffers from low bioavailability, the requirement frequent long-term use, and side effects. With similar structure as minoxidil, kopexil kopyrrol are less toxic have been commercialized, but show an inferior hair regeneration effect compared to minoxidil. Herein, we developed hyaluronic acid (HA)-based dissolvable microneedles (MNs) delivery platform integrated with coencapsulated nanoliposomes (KK-NLPs) effectively safely treat AGA. Facilitated by MNs, encapsulated KK-NLPs performed efficient skin penetration enhanced cellular internalization into human dermal papilla cells. Furthermore, within target cells, codelivered synergistic effects orchestrating upregulation in expression Ki67, β-catenin, vascular endothelial growth factor (VEGF), CD31. These molecular responses collectively foster cell proliferation, migration, antioxidative effects, thereby facilitating expedited progression follicles (HFs) anagen phase promoting peripheral angiogenesis. Notably, KK-NLPs-integrated MNs treatment group exhibits noteworthy vivo, identical or superior therapeutic at much lower dosage than that results suggest great potential this codelivery nanoliposomes-integrated AGA safe way.
Language: Английский
Citations
13Advanced Drug Delivery Reviews, Journal Year: 2024, Volume and Issue: 207, P. 115198 - 115198
Published: Feb. 9, 2024
Language: Английский
Citations
12International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 652, P. 123826 - 123826
Published: Jan. 21, 2024
Language: Английский
Citations
11